JustAnswer(R) and Glaucoma Research Foundation Help Individuals See the Light in Preventing Blindness

...nday-Friday, 12:30-1:30 p.m. ET); Dr. Andrew Rabinowitz, author of several published glaucoma research works and recipient of the prestigious pharmacia Top Doc Award in 2001 (Monday-Thursday, 3:00-4:00 p.m. ET); and Dr. Bradley Schuster, University of Colorado assistant clinical professor an...

Astellas Names Head of Global R&D Operations

... president of global clinical operations at Johnson & Johnson Pharmaceutical Research and Development. Dr. Carberry began his industry career with pharmacia at the Kalamazoo Research site where he held positions of increasing responsibility across the development organization. Carberry earned his M.D. at t...

Astellas Hires New Vice President of Compliance

...cal experience, which will accelerate Astellas toward our company goals." Prior to joining Astellas, Dunham held legal positions at Pfizer Inc., pharmacia Corporation and Warner-Lambert Company. He managed civil and criminal investigations into manufacturing, laboratory, marketing and promotion and prici...

CareFusion Names Edward Borkowski as Chief Financial Officer

...ent of global finance and information technology of consumer health care at pharmacia Corporation. Through his various leadership positions with Mylan, pharmacia and American Home Products Corporation, Borkowski has gained broad knowledg...

Parkinson's Treatment Drugs Even Out Over Long Term

...ts' quality of life or disability, the researchers found. The study, published online March 9 in the journal Archives of Neurology , was funded by pharmacia Corp. and Boehringer Ingelheim. More information We Move has more about Parkinson's disease . -- Robert Preidt ...

Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO

... Sensus Drug Development Corporation, where he led the development and commercialization of the endocrine product Somavert(R). Sensus was acquired by pharmacia in 2001. Previously, he co-founded Covance Biotechnology Services, Inc., a contract recombinant protein manufacturing company, and was head of the No...

Former Johnson & Johnson Executive Gives Big Voice to Small Companies

...'s image and products from a commercial, research & development, and manufacturing perspective. Prior to that, Michael held executive positions at pharmacia Corporation and Searle Pharmaceuticals, and led efforts related to the launch of a number of blockbuster products. Michael has been a pioneer in soci...

Ozmosis and the Doctor's Channel Revolutionize Online Medical Knowledge Exchange With Video Content

...ed Saatchi & Saatchi's medical education company BESTMED. Both doctors have worked in the pharmaceutical industry, with Dr. Banks having experience at pharmacia and Pfizer and Best at Bristol-Myers Squibb. The Doctor's Channel and thedoctorschannel.com are trademarks or registered trademarks of The Doctor's ...

Hagens Berman: Eleven Defendants Settle in Average Wholesale Price Litigation

...., Baxter International Inc., Bayer Corporation, Dey, Inc., Fujisawa Healthcare, Inc., Fujisawa USA, Inc., Immunex Corporation, Pharmacia Corporation, pharmacia & Upjohn LLC, Sicor, Inc., Gensia, Inc., Gensia Sicor Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc., and ZLB Behring, L.L.C. Drugs covered in ...

Healthcare Businesswomen's Association Names Genentech's Leonard Kanavy, Vice President, Commercial Operations as the 2008 Honorable Mentor

...eldon, then President and COO, Eisai Inc. -- 2002 -- Timothy Rothwell, then Executive Vice President and President, Global Prescription Business for pharmacia Corporation -- 2003 -- Ronald W. Dollens, then President and CEO, Guidant Corporation -- 2004 -- David Epstein, President of Novartis Oncology -...

Pharmacia in Medical Technology

Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development

... II study that is currently being conducted by the European Organization for Research and Treatment of Cancer (EORTC). Brostallicin was discovered at pharmacia and developed by Nerviano Medical Sciences (NMS) the largest pharmaceutical research and development facility in Italy and one of the largest oncology...

Pharmacia in Medical Products

The Nichamin Inserter

Description:... This inserter is designed for insertion of Alcon Acrylic, Chiron/Iolab LI-41 and pharmacia & Upjohn 920 Ceeon foldable lenses. The blades are taller and thinner, maximizing the surface area around the folded optic. This feature prevents lens...
Company:Rhein Medical, Inc.

Fine III Inserter

Description:... This titanium inserter is designed for insertion of Alcon Acrylic, AMO SI-30 and SI-40, Chiron/Iolab LI-41, and pharmacia & Upjohn 920 Ceeon foldable lenses. The special direct-acting jaws release the lens slowly and with complete control, and the blades are bowed to exer...
Company:Rhein Medical, Inc.

Pharmacia in Biological Technology

Signostics Closes Follow-On Financing of US$4 Million, Expands Board of Directors

... David Fisher has over 25 years experience in the biotechnology and medical devices sector, including CEO of Peptech Ltd, senior roles with pharmacia AB in Sweden, and is currently Managing Director of Brandon Capital Partners, an Australian venture capital firm. Amanda Heyworth is CEO o...

Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer

... sales. Prior to PTC, he was vice president in research and development at pharmacia Corporation and held executive positions at Merck Research Laboratories in ...rldwide basic and External research, Merck), Dr. John Zabriskie (former CEO pharmacia & Upjohn), and Daphne Zohar (PureTech founder and managing partner). ...

Pharmalink AB Strengthens its Board of Directors and Signals a Strategic Step Towards Late Phase Product Development

...nc. Previously, Mr Wiklund spent 29 years with the pharmacia Group of companies in a number of executive positions, ultimately serving as President of pharmacia Development Corp and Vice President of pharmacia Upjohn, working in the US. In his advisory role, M...

Kendle Reappoints Former CFO Timothy M. Mooney to Board of Directors

...r, Beacon Roofing Supply, Inc.; G. Steven Geis, PhD, M.D., Retired, Group Vice President: Arthritis, Cardiovascular and Oncology Clinical Development, pharmacia & Upjohn Company; Donald C. Harrison, M.D., Senior Vice President and Provost for Health Affairs Emeritus, University of Cincinnati; Timothy E. Johnso...

Alba Therapeutics Corporation Announces Promotions

...e, oncology and CNS arenas. Kate has extensive experience in the diagnostic business and previously worked for Ortho Diagnostic Systems, Inc. and with pharmacia where she helped develop diagnostic tools for pregnancy, HIV, Hepatitis B, and blood banking reagents. Ms. Huber received her MBA from Rider College i...

Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications

...thcare practice of Fleishman-Hillard International Communications. He previously served in senior level Communications and Public Policy positions for pharmacia Corporation, Bayer Corporation's Pharmaceutical Division, the Bristol-Myers Squibb Company, and Hoffmann-La Roche Inc. "Wyeth is in one of the most ...

Horizon Therapeutics Announces Corporate Relocation to the Chicago Area

...s new headquarters in early August at the Illinois Science and Technology Park in Skokie, Ill., which formerly housed the Searle and then subsequently pharmacia and Pfizer research and development offices. Horizon has approximately 50 full-time employees and consultants. Mr. Walbert, who was recently named p...

Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team

...enue with an announceable value in excess of $1 billion dollars, and included agreements with BMS, Lilly, Warner Lambert, Merck, F. Hoffmann La Roche, pharmacia Upjohn, Kraft Foods, Campbell's Soup, Nestle and the Coca Cola Company. Grayson was a founding member of the management team of Aurora Biosciences and...

Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement

...inger Ingelheim, Dr. Dohlsten spent more than 15 years in various leadership roles in pharmaceutical research including positions with AstraZeneca and pharmacia & Upjohn. Dr. Dohlsten earned his Ph.D. in tumor immunology and M.D. from the University of Lund in Sweden. He also studied virology and cell biolog...

RiverVest Venture Partners(R), a St. Louis-Based Venture Capital Firm Focusing on Life Sciences, Closes on Fund II, Names John P. McKearn, Ph.D., Venture Partner

...earch and development at Kalypsys, Inc., Pharmacia, G.D. Searle & Co., and E.I. DuPont de Nemours and Company. "We've known John since Pfizer bought pharmacia back in 2003 and have kept in close contact ever since," said Mr. Schmelter. "John's strong scientific training and operational expertise will further...